Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Griffonia simplicifolia isolectin B4 identifies a specific subpopulation of angiogenic blood vessels following contusive spinal cord injury in the adult mouse.

The Journal of comparative neurology | 2008

After traumatic spinal cord injury (SCI), disruption and plasticity of the microvasculature within injured spinal tissue contribute to the pathological cascades associated with the evolution of both primary and secondary injury. Conversely, preserved vascular function most likely results in tissue sparing and subsequent functional recovery. It has been difficult to identify subclasses of damaged or regenerating blood vessels at the cellular level. Here, adult mice received a single intravenous injection of the Griffonia simplicifolia isolectin B4 (IB4) at 1-28 days following a moderate thoracic (T9) contusion. Vascular binding of IB4 was maximally observed 7 days following injury, a time associated with multiple pathologic aspects of the intrinsic adaptive angiogenesis, with numbers of IB4 vascular profiles decreasing by 21 days postinjury. Quantitative assessment of IB4 binding shows that it occurs within the evolving lesion epicenter, with affected vessels expressing a temporally specific dysfunctional tight junctional phenotype as assessed by occludin, claudin-5, and ZO-1 immunoreactivities. Taken together, these results demonstrate that intravascular lectin delivery following SCI is a useful approach not only for observing the functional status of neovascular formation but also for definitively identifying specific subpopulations of reactive spinal microvascular elements.

Pubmed ID: 18092342 RIS Download

Associated grants

  • Agency: NCRR NIH HHS, United States
    Id: P20 RR015576
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS045734-04
  • Agency: NINDS NIH HHS, United States
    Id: NS045734
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS045734
  • Agency: NCRR NIH HHS, United States
    Id: P20 RR015576-09
  • Agency: NCRR NIH HHS, United States
    Id: RR15576

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Adobe Illustrator (tool)

RRID:SCR_010279

Vector graphics software to create digital graphics, illustrations, and typography for several types of media: print, web, interactive, video, and mobile.

View all literature mentions

Anti-Desmin (antibody)

RRID:AB_2092609

This polyclonal targets Desmin

View all literature mentions

CD31 (antibody)

RRID:AB_393571

This monoclonal targets CD31

View all literature mentions

Ki-67 (antibody)

RRID:AB_442102

This unknown targets Prokaryotic recombinant fusion protein corresponding to a 1086bp Ki67 motif-containing cDNA fragment

View all literature mentions

Anti-Laminin antibody produced in rabbit (antibody)

RRID:AB_477163

This polyclonal targets Laminin antibody produced in rabbit

View all literature mentions

Anti Iba1, Rabbit antibody (antibody)

RRID:AB_839504

This polyclonal targets Iba1

View all literature mentions

Anti-AIF, internal domain (antibody)

RRID:AB_90857

This polyclonal targets AIF (Apoptosis Inducing Factor), Internal Domain

View all literature mentions

Anti-NG2 Chondroitin Sulfate Proteoglycan (antibody)

RRID:AB_91789

This polyclonal targets NG2 Chondroitin Sulfate Proteoglycan

View all literature mentions